-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VctkMwkptlf997NraXvATA1K4l0c/xxg3fEzcRh0AzGjd8G4iSIDu4QiQKiXqjMS xHTtIGGjnKklzwydKfIOhw== 0001275187-04-000012.txt : 20040526 0001275187-04-000012.hdr.sgml : 20040526 20040526184246 ACCESSION NUMBER: 0001275187-04-000012 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20040526 FILED AS OF DATE: 20040526 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ANGIODYNAMICS INC CENTRAL INDEX KEY: 0001275187 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 113146460 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 BUSINESS ADDRESS: STREET 1: 603 QUEENSBURY AVE CITY: QUEENSBURY STATE: NY ZIP: 12804 BUSINESS PHONE: 5187981215 MAIL ADDRESS: STREET 1: 603 QUEENSBURY AVE CITY: QUEENSBURY STATE: NY ZIP: 12804 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLD JEFFREY CENTRAL INDEX KEY: 0000938659 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50761 FILM NUMBER: 04833340 BUSINESS ADDRESS: STREET 1: C/O CRYOVASCULAR SYSTEMS STREET 2: 160 KNOWLES DR CITY: LOS GATOS STATE: CA ZIP: 95032 BUSINESS PHONE: 6505669091 MAIL ADDRESS: STREET 1: 596 HOPKINS ST CITY: MENLO PARK STATE: CA ZIP: 94025 3 1 primary_doc.xml PRIMARY DOCUMENT X0202 3 2004-05-26 0 0001275187 ANGIODYNAMICS INC ANGO 0000938659 GOLD JEFFREY 596 HOPKINS ST MENLO PARK CA 94025 1 0 0 0 Common stock options (right to buy) 4.35 2007-03-04 Common stock 26136 D Common stock options (right to buy) 4.35 2008-05-30 Common stock 2091 D Common stock options (right to buy) 4.35 2009-05-29 Common stock 2091 D Common stock options (right to buy) 4.35 2010-06-03 Common stock 2091 D Common stock options (right to buy) 4.35 2011-06-02 Common stock 2091 D Common stock options (right to buy) 6.52 2012-05-21 Common stock 2091 D Common stock options (right to buy) 6.52 2013-05-31 Common stock 6273 D Exercisable upon the earlier of 8/2/2005 or two months after the distribution by E-Z-EM, Inc. of all of its shares of AngioDynamics, Inc. common stock to its stockholders. Options for 80% of the shares will become exercisable on the earlier of 8/2/2005 or two months after the distribution by E-Z-EM, Inc. of all of its shares of AngioDynamics, Inc. common stock to its stockholders. Options for 20% of the shares will become exercisable on the later of 6/3/2005 or two months after the distribution by E-Z-EM, Inc. of all of its shares of AngioDynamics, Inc. common stock; provided, that if such distribution does not occur before 6/3/2005, then such options will become exercisable on 8/2/2005. Options for 60% of the shares will become exercisable upon the earlier of 8/2/2005 or two months after the distribution by E-Z-EM, Inc. of all of its shares of AngioDynamics, Inc. common stock to its stockholders. Options for 20% of the shares will become exercisable upon the later of 6/2/2005 or two months after the distrubtion by E-Z-EM, Inc. of all of its shares of AngioDynamics, Inc. common stock to its stockholders; provided, that if such distribution does not occur before 6/2/2005, then such options will become exercisable on 8/2/2005. Options for 20% of the shares will become exercisable on 6/2/2006. Options for 40% of the shares will become exercisable upon the earlier of 8/2/2005 or two months after the distribution by E-Z-EM, Inc. of all of its shares of AngioDynamics, Inc. common stock. Options for 20% of the shares will become exercisable on the later of 5/21/2005 or two months after the distribution by E-Z-EM, Inc. of all of its shares of AngioDynamics, Inc. common stock to its stockholders; provided that if such distribution does not occur before 05/21/2005, then such options will become exercisable on 08/02/2005. Options for 20% of the shares are each exercisable on 5/21/2006 and 5/21/2007, respectively. Options for 20% of the shares will become exercisable upon the earlier of 8/2/2005 or two months after the distribution by E-Z-EM, Inc. of all of its shares of AngioDynamics, Inc. common stock to its stockholders. Options for 20% of the shares will become exercisable on the later of 5/31/2005 or two months after the distribution by E-Z-EM, Inc. of all of its shares of AngioDynamics, Inc. common stock to its stockholders; provided, that if such distribution does not occur before 5/31/2005, then such options will become exercisable on 8/2/2005. Options for 20% of the shares are each exercisable on 5/31/2006, 5/31/2007, and 5/31/2008, respectively. Ronald F. Lamy as attorney in fact for Jeffrey Gold 2004-05-26 EX-24 2 goldpoa2004.txt POWER OF ATTORNEY POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints each of Joseph G. Gerardi and Ronald F. Lamy, signing singly, the undersigned's true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of AngioDynamics, Inc., Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder; (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5 and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 23rd day of April 2004. /s/ Jeffrey G. Gold -----END PRIVACY-ENHANCED MESSAGE-----